Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

AFC Gamma

JPMorgan BetaBuilders MSCI US REIT ETF

Canopy Growth

Amplify Seymour Cannabis ETF

Cronos Group

Curaleaf Holdings, Inc.

Direxion Daily Real Estate Bull 3x Shares

Direxion Daily Real Estate Bear 3x Shares

Fidelity MSCI Real Estate ETF

First Trust S&P REIT Index Fund

GrowGeneration Corp

Hydrofarm Holdings Group

iShares Cohen & Steers REIT ETF

Innovative Industrial Properties

iShares U.S. Real Estate ETF

Nuveen Real Estate Income Fund

Invesco KBW Premium Yield Equity REIT ETF

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

NewLake Capital Partners, Inc.

Neuberger Berman Real Estate Securities Income Fund Inc

Global X Cannabis ETF

US Diversified Real Estate ETF

Invesco Active US Real Estate

Power REIT

Chicago Atlantic Real Estate Finance

ProShares Short Real Estate

Cohen And Steers Total Return Realty Fund

Cohen & Steers Reit And Preferred Income Fund Inc

Cohen & Steers Quality Income Realty Fund

SPDR Dow Jones REIT ETF

Schwab U.S. REIT ETF

Seven Hills Realty Trust

Scotts Miracle-Gro

ProShares UltraShort Real Estate

Pacer Funds Trust-Pacer Benchmark Data & Infrastructure Real Estate Sector ETF

Trulieve Cannabis Corp.

Cambria Cannabis ETF

ProShares Ultra Real Estate

iShares Core U.S. REIT ETF

Village Farms International

Vanguard Real Estate ETF

Virtus Real Asset Income ETF

Real Estate Select Sector SPDR Fund

AdvisorShares Pure Cannabis ETF 

The previously high-flying cannabis REITs have been slammed this year on concerns over rent payment from their cannabis cultivator tenants, which have been struggling amid a plunge in wholesale cannabis prices. The 30-50% plunge in pot prices comes amid a flood of new entrants to the cannabis retail and cultivation industry and as institutional capital to multi-state operators has driven production-efficiencies.

Cannabis REITs: Too Cheap To Get High

At what price will marijuana stocks finally be cheap enough to buy?

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Bounced Back Monday

OrganiGram Holdings Inc.

Top Canadian Pot Stocks To Watch Before October 2022 The post Top Canadian Marijuana Stocks To Watch Last Week Of September appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Watch Last Week Of September

Vertex Pharmaceuticals

There are plenty of fierce headwinds in play, but that doesn't mean you should sit on the sidelines.

Is Now the Right Time to Be Buying Growth Stocks?

Cannabis legalization in Germany with Niklas Kouparanis, CEO and Co-Founder of Bloomwell Group - Germany's largest cannabis company. We talk about legalizing the whole value chain.

Cannabis In Germany - Legalize, Don't Decriminalize (Transcript)

NEW YORK and LEAMINGTON, Ontario, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that the Company will release financial results for its first quarter fiscal 2023 ended August 31, 2022 on October 7, 2022 at 8:30 an Eastern Time.

Tilray Brands, Inc. to Announce First Quarter Fiscal 2023 Financial Results on October 7, 2022

A Top Cannabis Executive Has 2 Bold Predictions for the Industry

Is the company setting investors up for a big disappointment?

1 Reason Tilray's Management Promises Could Go Up in Smoke

Tilray Brands Inc. TLRY, -3.25% on Thursday said its FL Group S.R.L. unit in Italy has received approval from the Italian ministry of health to import and distribute Tilray's medical cannabis oral solution THC25.

Tilray to sell cannabis products in Italy

Italian Ministry of Health Approves Tilray Branded Medical Cannabis for Pharmaceutical Distribution Italian Ministry of Health Approves Tilray Branded Medical Cannabis for Pharmaceutical Distribution

Tilray Medical Receives Approval to Extend Market Authorization in Italy

SNDL Inc.

It is probably the right time for you to think about some marijuana stocks to sell. Marijuana stocks have been a massive downer this year.

7 Marijuana Stocks to Sell Now

Top Canadian Marijuana Stocks To Watch 2022 The post Canadian Marijuana Stocks You Want To Know About Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks You Want To Know About Right Now

Marathon Digital Holdings

Electrameccanica

Finding the right stocks to buy for 1,000% gains in current market conditions seems challenging. However, it's not impossible.

3 Stock Investing Opportunities to Make 1,000% Gains

Altria

Every growth investor should consider having some exposure to the cannabis industry.

3 Ways to Invest In This Skyrocketing Growth Industry

To date, 37 states (plus the District of Columbia) have either decriminalized cannabis or enacted laws authorizing its use for medical or recreational purposes. Legalization initiatives have also been gaining momentum outside of the United States.

Cannabis Industry Update

With the widespread legalization of cannabis, founding partner of KEY Investment Partners Tiby Erdely, Sweet Leaf Madison Capital CFO Kevin Bush, Grassdoor CEO Zack Ein, Katalys co-founder and CRO Matt Stein, and Gordian Compliance Solutions COO Yulia Kalk joined the Future Proof panel The Cannabis Industry: How to Invest for the Future.

Future Proof: Cannabis Industry Is Planting Seeds of Innovation and Seeing Growth

Can Canadian Cannabis Stocks Continue To See Gains This Week? The post Best Canadian Cannabis Stocks To Watch 3rd Week Of September appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Cannabis Stocks To Watch 3rd Week Of September

Would a combined entity make for a better overall investment?

Is a Mega-Merger Between Tilray and SNDL Inevitable?

Mere survival won't be enough to wow investors, but it's definitely a prerequisite.

2 Bruised Growth Stocks That'll Survive the Bear Market

Tilray's portfolio of U.S. businesses is already profitable.

Why Tilray Brands Stock Rose Today

Flora Growth Corp

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

2 Cannabis Stocks Heat Up Holiday-Shortened Week

A gentle reminder that TLRY will be reporting FQ1'23 earnings on approximately 06 October 2022. Despite the massive hype surrounding cannabis legalization in 2021, the previously red-hot market has drastically cooled with no clear winners.

Tilray: Hype Train Crashed

Award-Winning Portfolio of Breckenridge Spirits Are Now Available Coast to Coast Award-Winning Portfolio of Breckenridge Spirits Are Now Available Coast to Coast

Breckenridge Distillery Announces Nationwide Alignment and Renewed Distribution Agreement With Republic National Distributing Company

Tilray is near a 52-week low but can new products and potential new legalization may reignite the stock? The post Is TLRY Stock A Buy As Germany Gets Closer To Cannabis Legalization?

Is TLRY Stock A Buy As Germany Gets Closer To Cannabis Legalization?

News for Tilray Brands Stock (TLRY)